The Food and Drugs Authority (FDA) has issued a nationwide alert over falsified Dr. Alfred Capsules adulterated with Sildenafil Citrate, a prescription‑only drug used to treat erectile dysfunction and pulmonary arterial hypertension.
According to the FDA, regulatory intelligence and enforcement operations uncovered an organized syndicate in Accra and Suhum manufacturing and distributing the falsified capsules across social media platforms. Two suspects linked to the illicit activity are currently on police enquiry bail while investigations continue.
Laboratory analysis conducted by the FDA’s Centre for Laboratory Services and Research confirmed that the falsified variants contain Sildenafil Citrate, an undeclared pharmaceutical substance posing a critical public health risk. The registered product, manufactured in Indonesia and distributed locally by Unateus Ghana Limited, does not contain Sildenafil Citrate.
The FDA highlighted stark differences between the registered and falsified products. Authentic capsules are wine‑red in color with uniform off‑white powder content, packaged in premium black bottles with traceable batch numbers. In contrast, falsified versions appear in white bottles with poor print quality, mismatched or fictitious batch numbers, and capsule shells ranging from transparent to black‑and‑red, containing greenish‑brown powder.
The Authority cautioned pharmacies, herbal shops, and distributors to inspect their stock and report any suspected falsified products. Consumers in possession of the falsified capsules are advised to return them to the nearest FDA regional office.
Leave a Reply